Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:27 PM
Ignite Modification Date:
2025-12-24 @ 4:27 PM
NCT ID:
NCT00974766
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of ABPA
* Presence of all the following three criteria:
1. immediate cutaneous hyperreactivity on aspergillus skin test
2. elevated total IgE levels \> 1000 IU/mL
3. A fumigatus specific IgE levels \> 0.35 kU/L, AND,
* Presence of two of the following criteria:
1. presence of serum precipitating antibodies against A fumigatus
2. fixed or transient radiographic pulmonary opacities
3. absolute eosinophil count \> 1000/µL
4. central bronchiectasis on HRCT
Exclusion Criteria:
* If they have taken glucocorticoids for more than three weeks in the preceding six months
* Failure to give informed consent
* Enrollment in another trial of ABPA
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00974766
Study Brief:
Protocol Section:
NCT00974766